ARCHIVES

Dasatinib, Nilotinib Show Strong Early Results As Frontline Therapy For CML

This article is from The Cancer Letter archive.

Vol. 30 No. 12 | December 28, 2007

Download PDF Visit The Full Archive

Related Articles

Harvard’s DePinho Becomes Finalist at MD Anderson

May 20, 2011

NIH Negotiating On Straus Grant; Committee Asks for One Probe

July 17, 1981

Chart Show 1980 Budget Breakown By Mechanisms, Research Programs, Compare Them With Previous Years

June 9, 1978

Scientists, advocates voice objections to von Eschenbach’s conflicts, 2015.

November 23, 2005

NCI Advisory Group, Other Cancer Meetings For May, June

April 30, 1976

ACS Forms Foundation To Handle Large Gifts

September 4, 1992